| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 123.21M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RCKT returned -3.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.0% |
| 1 year | -3.6% |
| 5 years | -89.7% |
| 10 years | -87.6% |
| All-time high | $55.58 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RCKT would be worth today ›No. Rocket Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Rocket Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol RCKT.
Rocket Pharmaceuticals, Inc. is part of the Healthcare sector.
Rocket Pharmaceuticals, Inc. has a market cap of 385.31M USD, based on the latest quote.
Rocket Pharmaceuticals, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
